Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small interfering RNA: Discovery, pharmacology and clinical development—An introductory review
Priyanga Ranasinghe, Melisande L. Addison, James W. Dear, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 21, pp. 2697-2720
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis
Shengting Dong, Huapan Fang, Junjie Zhu, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
Recent Advance of Liposome Nanoparticles for Nucleic Acid Therapy
Yongguang Gao, Xinhua Liu, Na Chen, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 178-178
Open Access | Times Cited: 35
Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events
Emanuel Raschi, Manuela Casula, Arrigo F.G. Cicero, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108507-108507
Open Access | Times Cited: 34
Nanoparticles and siRNA: A new era in therapeutics?
María Dolores Pérez‐Carrión, Inmaculada Posadas, Valentı́n Ceña
Pharmacological Research (2024) Vol. 201, pp. 107102-107102
Open Access | Times Cited: 14
Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?
Henriette Thau, Sebastian Neuber, Maximilian Y. Emmert, et al.
Cardiology and Therapy (2024) Vol. 13, Iss. 1, pp. 39-67
Open Access | Times Cited: 10
Role of Macromolecules in Medical Application: Challenges and Opportunities
Phool Chandra, Shahjad, Krishna Kumar Sharma, et al.
Macromolecular Symposia (2024) Vol. 413, Iss. 1
Closed Access | Times Cited: 10
Advances of Layered Double Hydroxide‐Based Materials for Tumor Imaging and Therapy
Ke Ma, Kezheng Chen, Sheng‐Lin Qiao
The Chemical Record (2024) Vol. 24, Iss. 4
Closed Access | Times Cited: 10
Translation of mechanistic advances in preeclampsia to the clinic: Long and winding road
Ravi Thadhani, Ana Sofia Cerdeira, S. Ananth Karumanchi
The FASEB Journal (2024) Vol. 38, Iss. 3
Closed Access | Times Cited: 9
Crisis averted: a world united against the menace of multiple drug-resistant superbugs -pioneering anti-AMR vaccines, RNA interference, nanomedicine, CRISPR-based antimicrobials, bacteriophage therapies, and clinical artificial intelligence strategies to safeguard global antimicrobial arsenal
Umar Saeed, Rawal Alies Insaf, Zahra Zahid Piracha, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 19
Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging
Ibrahim Alradwan, Nojoud AL Fayez, Mohammad N. Alomary, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1037-1037
Open Access | Times Cited: 6
Recent Advances and Prospects in RNA Drug Development
Hidenori Tani
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12284-12284
Open Access | Times Cited: 6
Advancements and future prospects of adeno-associated virus-mediated gene therapy for sensorineural hearing loss
Linke Li, Tian Shen, Shixi Liu, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
siRNA as potential therapeutic strategy for hypertension
Srushti Tanna, Gaurav Doshi, Angel Godad
European Journal of Pharmacology (2024) Vol. 969, pp. 176467-176467
Closed Access | Times Cited: 5
The discovery of a catalytic RNA within RNase P and its legacy
Leif A. Kirsebom, Fenyong Liu, William H. McClain
Journal of Biological Chemistry (2024) Vol. 300, Iss. 6, pp. 107318-107318
Open Access | Times Cited: 5
siRNA therapy in osteoarthritis: targeting cellular pathways for advanced treatment approaches
Yunshen Li, Jianan Zhao, Shicheng Guo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Advances in nucleic acid-targeted therapies for cardiovascular disease prevention
Umidakhon Makhmudova, Elisabeth Steinhagen‐Thiessen, Massimo Volpe, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 10, pp. 1107-1125
Open Access | Times Cited: 5
Novel pharmacological approaches to lowering blood pressure and managing hypertension
Matthew Sayer, David J. Webb, Neeraj Dhaun
Nature Reviews Cardiology (2025)
Closed Access
RNA-based Therapeutics: Past, Present and Future Prospects, Challenges in Cancer Treatment
Anjana Goel, Amisha Rastogi, M. Jain, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 16, pp. 2125-2137
Closed Access | Times Cited: 4
Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities
Kailash Ahirwar, Ankit Kumar, Nidhi Srivastava, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131048-131048
Closed Access | Times Cited: 4
Advancements in long non-coding RNA-based therapies for cancer: targeting, delivery, and clinical implications
Muhammad Ammad, Zeeshan Javed, Haleema Sadia, et al.
Medical Oncology (2024) Vol. 41, Iss. 11
Closed Access | Times Cited: 4
Small Interfering RNA Therapy for the Management and Prevention of Hypertension
Liwei Ren, A.H. Jan Danser
Current Hypertension Reports (2025) Vol. 27, Iss. 1
Open Access
A Method for siRNA-Mediated Knockdown of Target Genes in RA-Induced Neurogenesis Using P19 Cells
Hossein Khodadadi, Hiroaki Taniguchi
MethodsX (2025) Vol. 14, pp. 103177-103177
Open Access
Epigenetic modulation by oncolytic viruses: Implications for cancer therapeutic efficacy
Muhammad Haris Sultan, Qi Zhang, Hao Jin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189270-189270
Closed Access
siRNA therapeutics for effective management of rheumatoid arthritis
Vishakha R. Chakole, Tathagata Dutta, Priyankar Sen
Next Nanotechnology (2025) Vol. 7, pp. 100135-100135
Open Access
Page 1 - Next Page

Scroll to top